S7 Basic Research 1 : Recent advances in engineering for glucose sensing and control LIVE Channel C |
09:00~11:00 / Friday 8 October Chairman:Minho Shong |
Overview |
---|---|---|
There have been many technological progresses in glucose monitoring and automatic insulin delivery using wearable devices. In this session, four speakers in the field of engineering with original technologies will deliver lectures focused on these recent advances. This session will be a good opportunity to have interdisciplinary discussion among diabetologists, basic scientists, and engineers. | ||
|
S7-1Glucose sensor for diabetes using acoustic resonance in helmholtz resonator | |
|
S7-2Noninvasive glucose monitoring using spectroscopy | |
|
S7-3Ultra-fast insulin and insulin-pramlintide formulations for improving closed-loop control by more closely mimic pancreatic regulatory function | |
|
S7-4Glucose-responsive smart insulin delivery |
S8 Translational Research 1 : Adipocyte beiging to combat human and murine obesity LIVE Channel D |
09:00~11:00 / Friday 8 October Chairman:Chul-Hee Kim, Min-Seon Kim |
Overview |
---|---|---|
The title of this session is "Adipocyte beiging to combat human and murine obesity", and is designed to provide the translational research of the beiging of adipose tissue. Obesity treatment is based on reducing the calorie intake or increasing energy expenditure. Recently, a strategy to induce browning of white adipose tissue could be potentially useful in the treatment of obesity. This session will present new concepts regarding potential therapeutic approaches in the strategy of white adipose tissue browning. | ||
|
S8-1Cell reprogramming using extracellular vesicles from differentiating stem cells into white/beige adipocytes | |
|
S8-2Signaling roles of Hippo kinases in adipocytes and its therapeutic targeting in obesity-related metabolic disease. | |
|
S8-3 Bioenergetics matters to metabolic health – from a view of brown fat | |
|
S8-4Adipokines and immunological factors involved in browning and thermogenesis of adipose tissue |
S11 Basic Research 2 : Metabolomics analysis in complex human disease LIVE Channel C |
13:20~15:20 / Friday 8 October Chairman:In-Kyu Lee, Choon Hee Chung |
Overview | |||
---|---|---|---|---|---|
Metabolic flux is one of the most important phenotypes that can be measured for a cell. Metabolic flux analysis in physiology and pathology is opening up new avenues for diagnostic and therapeutic interventions. In this session titled, ‘Metabolomics, metabolic flux analysis, and complex human diseases’, four speakers with extensive experience in the field of metabolism will deliver a lecture on the role of metabolites and metabolic fluxes in complex human diseases. | |||||
|
S11-1Compartmentalized metabolomics reveals a substantial role of NAD+ in mitochondrial DNA maintenance | ||||
|
S11-2Biochemical mechanisms underlying fuel metabolism and the physiological relevance in human diseases | ||||
|
S11-3Metabolic flux analysis- a useful tool to detect cellular metabolic reprogramming in inflammatory diseases | ||||
|
S11-4Quantitative flux analysis of mammalian organ metabolism | ||||
|
S16 Translational Research 2 : What and how should we eat to maintain metabolic health? LIVE Channel D |
09:00~11:00 / Saturday 9 October Chairman:Myung-Shik Lee, Dae Ho Lee |
Overview |
---|---|---|
This session entitled “What and how should we eat to maintain metabolic health?” is a basic and translational session designed to provide recent insights on microbiome research for both basic researchers and clinicians. How gut microenvironment affects NAFLD, diabetes, and obesity will be broadly presented and discussed by our outstanding researchers both in translational and clinical perspectives. This session will also cover our recent discovery of the relationship between microbial metabolites and the response of oral anti-diabetic agents. | ||
|
S16-1Intestinal microbiome and metabolic-associated fatty liver disease | |
|
S16-2Multiomics approach for developing novel microbiome therapeutics against chronic metabolic diseases | |
|
S16-3Gut microbiota and type 2 diabetes | |
|
S16-4Microbiome modulators in obesity and diabetes by improving calorie sensing |